BCOR and acute myeloid leukemia: In one study, mutations in the BCOR gene were found to occur at a higher frequency in patients with primary refractory AML and a mouse model with BCOR deletion showed increased resistance to the chemotherapeutic drug cytarabine, including by whole-exome sequencing (63).